Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b

Published:2020-12-03 Issue: Volume:Publish Ahead of Print Page:
ISSN:0277-3740
Container-title:Cornea
language:en
Short-container-title:

Author:

Shields Carol L.,Paulose Sefy A.,Yaghy Antonio,Dalvin Lauren A.,Constantinescu Alexandru B.,Lally Sara E.,Shields Jerry A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demographics, clinical presentation and risk factors of ocular surface squamous neoplasia at a tertiary hospital, South Africa;Eye;2023-05-31

2. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia;The Ocular Surface;2023-04

3. Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight);Ophthalmology Science;2023-03

4. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study;The Ocular Surface;2023-01

5. The Management of Ocular Surface Squamous Neoplasia (OSSN);International Journal of Molecular Sciences;2022-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP